Prevalence Of Psoriasis Driving Market Growth: A Key Catalyst Accelerating Psoriasis Market Growth in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the recent years, there has been a robust growth in the size of the psoriasis market. It is estimated to rise from $26.45 billion in 2024 to $28.93 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%. Factors such as epidemiology, increased patient awareness and education, and the state of healare infrastructure and access have contributed to this growth during the historical period.

Psoriasis Market Size Forecast: What's the Projected Valuation by 2029?
In the upcoming years, the psoriasis sector is anticipated to witness robust expansion. The market is projected to inflate to "$40.93 billion by 2029, with a CAGR of 9.1%. The escalation in the predicted timeframe is due to regulatory greenlights, patient predilections, a growing elderly population, heightened awareness, and the roll-out of innovative treatments. The key trends expected to shape the forecasted period comprise breakthroughs in R&D, biologics and tailored treatments, orally administered minuscule molecule therapies, custom medicine, digital health and telemedicine, patient-focused care, biosimilars, as well as artificial intelligence and machine learning.

View the full report here:
https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report

What Are the Drivers Transforming the Psoriasis Market?
The escalation in the number of psoriasis sufferers is accelerating the Psoriasis market. Psoriasis stems from the immune system, heredity, and surroundings. Factors like climate change, stress, and poor lifestyle have majorly contributed to the increase in psoriasis patients in recent years. As per the data from the World Psoriasis Day consortium, psoriasis affects 125 million people worldwide, which is 2 to 3% of the total population. Consequently, the surge in the number of psoriasis cases is anticipated to boost the Psoriasis market's expansion during the prediction period.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp

Which Emerging Trends Are Transforming the Psoriasis Market in 2025?
The psoriasis market is seeing a rise in the use of combination therapy. This approach entails the simultaneous use of two distinct treatments for psoriasis. When you pair up two drugs with unique action mechanisms (referred to as combination therapy), it has a broader impact than monotherapy, which involves only one drug. Research points out that combination therapy can alleviate psoriasis symptoms more efficiently than a solitary treatment and has fewer side effects. The pairing of taltz (ixekizumab) and methotrexate, contrived by Eli Lilly and Company, is a case in point of combination therapy for active psoriatic arthritis (PsA).

Which Segments in the Psoriasis Market Offer the Most Profit Potential?
The psoriasis market covered in this report is segmented -

1) By Drug class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor
2) By Drug Types: Small molecules, Biologics
3) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis
4) By Route Of Administration: Oral, Tropical, Injectable
5) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce

Subsegments:
1) By Interleukin Inhibitors: IL-12/23 Inhibitors (Ustekinumab), IL-17 Inhibitors (Secukinumab, Ixekizumab)
2) By Corticosteroids: Topical Corticosteroids (Hydrocortisone, Betamethasone), Systemic Corticosteroids (Prednisone)
3) By Anti-Inflammatory: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Biologic Anti-Inflammatory Agents (Apremilast)
4) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2414&type=smp

Which Firms Dominate the Psoriasis Market by Market Share and Revenue in 2025?
Major companies operating in the psoriasis market include AbbVie Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Celgene Corporation, Johnson & Johnson, Amgen Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Janssen Biotech Inc., Takeda Pharmaceutical Company Limited, Stiefel Laboratories Inc., AstraZeneca Inc., Union Chimique Belge SA, Sun Pharmaceutical Industries Ltd., Forward Pharma AS, Almirall SA, Bausch Health Companies Inc., Biogen Inc., Biocon Biopharmaceuticals Pvt. Ltd., Celltrion Inc., Dr.Reddy's Laboratories Inc., Arcutis Biotherapeutics Inc., Bayer AG, Bristol Myers Squibb Co., Dermira Inc., Galderma SA, GlaxoSmithKline Plc, Incyte Pharmaceuticals Corp., LEO Pharmacy

Which Regions Offer the Highest Growth Potential in the Psoriasis Market?
North America was the largest region in the psoriasis market in 2024. Middle East is expected to be the fastest-growing region in the psoriasis market during the forecast period. The regions covered in the psoriasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2414

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.